1-5 of 5
Kinuko Mitani, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Adverse Risk Factors for Survival in Acquired Pure Red Cell Aplasia Receiving Immunosuppressive Therapy By the Japan PRCA2004/2006 Study and Introduction to the New Cohort Study PRCA2016

Makoto Hirokawa, MD PhD, Naohito Fujishima, MD, Masanao Teramura, MD, Kenichi Sawada, MD, Masami Bessho, MD, Kazuo Dan, MD, Hisashi Tsurumi, MD, Shinji Nakao, MD PhD, Akio Urabe, MD, Shin Fujisawa, MD PhD, Yuji Yonemura, MD PhD, Fumio Kawano, MD, Koichi Sugimoto, MD, Akira Matsuda, MD, Masamitsu Karasawa, MD, Ayako Arai, MD, PhD, Norio Komatsu, MD, Hideo Harigae, MD, Kaoru Tohyama, MD, Saito-Moriya Akiko, MD, Itaru Matsumura, MDPhD, Mitsuhiro Omine, MD, Keiya Ozawa, MD, Mineo Kurokawa, MD PhD, Shunya Arai, MD, Kinuko Mitani, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4954.
https://doi.org/10.1182/blood.V130.Suppl_1.4954.4954
Published: 2017
Journal Articles

Contribution of MIR9 on Disease Progression of Chronic Myelogenous Leukemia

Ko Sasaki, MD PhD, Fusako Nagasawa, MD, PhD, Kenichi Yoshida, MD PhD, June Takeda, MD, Yuichi Shiraishi, PhD, Kenichi Chiba, B.A., Hiroko Tanaka, B.A., Ai Okada, Satoru Miyano, PhD, Motoshi Ichikawa, MD, PhD, Seishi Ogawa, MD PhD, Kinuko Mitani, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4972.
https://doi.org/10.1182/blood.V130.Suppl_1.4972.4972
Published: 2017
Journal Articles

Successful MPB Therapy Followed By Bortezomib Maintenance for Non-Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Japanese Phase 2 Study - Broad-J Study

Michihide Tokuhira, MD, Naoki Takezako, MD PhD, Yoichi Imai, MD PhD, Tadao Ishida, MD, Tomonori Nakazato, MD PhD, Kinuko Mitani, MD, PhD, Tohru Ikuta, MDPhD, Morio Matsumoto, MD, Takayuki Ikezoe, MD, PhD, Jun Taguchi, MD PhD, Kensuke Usuki, MD PhD, Takeshi Shimomura, MD, Kenkou Chin, MD, Shunya Arai, MD PhD, Kazuma Ohyashiki, MD, Miho Nara, MD, Kenji Kishi, MD, Yoshiaki Kuroda, MD, Yuichi Nakamura, MD, Hisashi Wakita, MD PhD, Makoto Sasaki, MD PhD, Hirotoshi Kamata, MD, Yoshikazu Ichikawa, MD, Akihiko Yokoyama, MD, Kenshi Suzuki, Masahiro Kizaki, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5432.
https://doi.org/10.1182/blood.V130.Suppl_1.5432.5432
Published: 2017
Journal Articles

A Randomized Study to Determine the Optimal Dose of Darbepoetin Alfa in Patients with Low- or Intermediate-1 Risk Myelodysplastic Syndromes

Hironori Harada, MD PhD, Hirohiko Shibayama, Jun Ho Jang, MD PhD, Ryutaro Shimazaki, Kinuko Mitani, MD, PhD, Kenichi Sawada, MD PhD, Hyeoung-Joon Kim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4642.
https://doi.org/10.1182/blood.V124.21.4642.4642
Published: 2014
Journal Articles

Multicenter Phase II Clinical Trial of Nilotinib for Patients with Imatinib-Resistant or Intolerant CML From the East Japan CML Study Group (EJCML) Trial: Evaluation of Molecular Responses by the BCR-ABL1 Mutational Status and Plasma Trough Concentration of Nilotinib

Naoto Takahashi, MD, PhD, Masatomo Miura, PhD, Jun Kuroki, MD, PhD, Kinuko Mitani, MD, PhD, Atsushi Kitabayashi, MD, PhD, Osamu Sasaki, MD, PhD, Hideo Kimura, MD, PhD, Kiyotoshi Imai, MD, PhD, Norifumi Tsukamoto, MD, PhD, Hideyoshi Noji, MD, PhD, Takeshi Kondo, MD, PhD, Akihisa Kuwayama, MD, PhD, Mutsuhito Motegi, MD, PhD, Yuichi Kato, MD, PhD, Kaoru Takahashi, MD, PhD, Masayuki Mita, MD, PhD, Hajime Saito, MD, PhD, Chikashi Yoshida, MD, PhD, Yoshihiro Torimoto, MD, PhD, Tomofumi Kimura, MD, PhD, Yuji Wano, MD, PhD, Jun Nomura, MD, PhD, Satoshi Yamamoto, MD, PhD, Ko Mayama, MD, PhD, Riko Honma, MD, PhD, Tomohiro Sugawara, MD, PhD, Shinji Sato, MD, PhD, Atsushi Shinagawa, MD, PhD, Akihiko Chubachi, MD, PhD, Hideo Harigae, MD, PhD, Kenichi Sawada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1360.
https://doi.org/10.1182/blood.V120.21.1360.1360
Published: 2012